相似文献
1
Do self-perpetuating B lymphocytes drive human autoimmune disease?
Immunology. 1999 Jun;97(2):188-96. doi: 10.1046/j.1365-2567.1999.00772.x.
2
The role of B cells in rheumatoid arthritis: mechanisms and therapeutic targets.
Curr Opin Rheumatol. 2003 May;15(3):246-52. doi: 10.1097/00002281-200305000-00011.
3
A disease-related rheumatoid factor autoantibody is not tolerized in a normal mouse: implications for the origins of autoantibodies in autoimmune disease.
J Exp Med. 1996 Oct 1;184(4):1269-78. doi: 10.1084/jem.184.4.1269.
4
Selfie: Autoimmunity, boon or bane.
J Immunoassay Immunochem. 2017;38(3):235-246. doi: 10.1080/15321819.2017.1319861. Epub 2017 Apr 19.
5
Autoimmunity in rheumatoid arthritis. An approach via a study of B lymphocytes.
Rheum Dis Clin North Am. 1987 Aug;13(2):319-38.
6
B cells in rheumatoid arthritis.
Autoimmun Rev. 2007 Dec;7(2):137-42. doi: 10.1016/j.autrev.2007.02.017. Epub 2007 Mar 26.
7
[Rheumatoid polyarthritis: the role of the immune system in the development of lesions].
Rev Med Interne. 1999;20 Suppl 1:27S-28S. doi: 10.1016/s0248-8663(99)80138-6.
8
Controversy in Medicine Debate: the defect in rheumatoid arthritis is inherent to the lymphocyte.
Eur J Clin Invest. 1984 Dec;14(6):403-7. doi: 10.1111/j.1365-2362.1984.tb01202.x.
9
B-cell targeting in rheumatoid arthritis and other autoimmune diseases.
Nat Rev Immunol. 2006 May;6(5):394-403. doi: 10.1038/nri1838.
10
[A new mechanism of autoantibody production: antigen presentation of misfolded protein by MHC class II].
Nihon Rinsho Meneki Gakkai Kaishi. 2014;37(6):462-7. doi: 10.2177/jsci.37.462.
引用本文的文献
1
Pharmacogenomics of Monoclonal Antibodies for the Treatment of Rheumatoid Arthritis.
J Pers Med. 2022 Jul 31;12(8):1265. doi: 10.3390/jpm12081265.
2
Possible Role of Regulatory B Cells in Different Behçet's Disease Phenotypes and Therapies: First Report from Egypt.
J Inflamm Res. 2021 Mar 8;14:737-744. doi: 10.2147/JIR.S279912. eCollection 2021.
3
Extracellular cyclic adenosine monophosphate-dependent protein kinase A autoantibody and C-reactive protein as serum biomarkers for diagnosis of cancer in dogs.
Vet Comp Oncol. 2019 Mar;17(1):99-106. doi: 10.1111/vco.12450. Epub 2018 Nov 28.
4
KDiamend: a package for detecting key drivers in a molecular ecological network of disease.
BMC Syst Biol. 2018 Apr 11;12(Suppl 1):5. doi: 10.1186/s12918-018-0531-8.
5
BANK1 alters B cell responses and influences the interactions between B cells and induced T regulatory cells in mice with collagen-induced arthritis.
Arthritis Res Ther. 2018 Jan 25;20(1):9. doi: 10.1186/s13075-017-1503-x.
6
Is Tolerance Broken in Autoimmunity?
Clin Med Insights Pathol. 2017 May 16;10:1179555717712716. doi: 10.1177/1179555717712716. eCollection 2017.
7
Safety and efficacy of ocrelizumab in rheumatoid arthritis patients with an inadequate response to methotrexate or tumor necrosis factor inhibitors: a systematic review and meta-analysis.
Rheumatol Int. 2017 Jul;37(7):1053-1064. doi: 10.1007/s00296-017-3675-8. Epub 2017 Feb 24.
8
Update on the use of rituximab for intractable rheumatoid arthritis.
Open Access Rheumatol. 2009 Jun 26;1:83-94. doi: 10.2147/oarrr.s4968. eCollection 2009.
9
Heterogeneity of B Cell Functions in Stroke-Related Risk, Prevention, Injury, and Repair.
Neurotherapeutics. 2016 Oct;13(4):729-747. doi: 10.1007/s13311-016-0460-4.
10
The biological challenge of myalgic encephalomyelitis/chronic fatigue syndrome: a solvable problem.
Fatigue. 2016 Apr 2;4(2):63-69. doi: 10.1080/21641846.2016.1160598. Epub 2016 Apr 28.
本文引用的文献
1
Differential distribution of Fc gamma RIIIa in normal human tissues and co-localization with DAF and fibrillin-1: implications for immunological microenvironments.
Immunology. 1998 May;94(1):56-63. doi: 10.1046/j.1365-2567.1998.00491.x.
2
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
J Clin Oncol. 1998 Aug;16(8):2825-33. doi: 10.1200/JCO.1998.16.8.2825.
3
Asymptomatic synovitis precedes clinically manifest arthritis.
Arthritis Rheum. 1998 Aug;41(8):1481-8. doi: 10.1002/1529-0131(199808)41:8<1481::AID-ART19>3.0.CO;2-O.
4
Triple check for antigen specificity of B cells during germinal centre reactions.
Immunol Today. 1997 Dec;18(12):573-7. doi: 10.1016/s0167-5699(97)01160-2.
5
Neutrophil Fc gamma and complement receptors involved in binding soluble IgG immune complexes and in specific granule release induced by soluble IgG immune complexes.
Eur J Immunol. 1997 Oct;27(10):2514-23. doi: 10.1002/eji.1830271008.
6
Apoptosis in the rheumatic diseases.
Arthritis Rheum. 1997 Nov;40(11):1917-27. doi: 10.1002/art.1780401102.
7
IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma.
J Clin Oncol. 1997 Oct;15(10):3266-74. doi: 10.1200/JCO.1997.15.10.3266.
8
The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion.
Brain. 1997 Aug;120 ( Pt 8):1461-83. doi: 10.1093/brain/120.8.1461.
9
Fc gamma receptor type IIb induced recruitment of inositol and protein phosphatases to the signal transductory complex of human B-cell.
Immunol Lett. 1997 Jun 1;57(1-3):159-64. doi: 10.1016/s0165-2478(97)00055-2.
10
Expression of molecules involved in B lymphocyte survival and differentiation by synovial fibroblasts.
Clin Exp Immunol. 1997 Jun;108(3):407-14. doi: 10.1046/j.1365-2249.1997.4061306.x.
Zotero 插件